“…Infants born SGA have increased mortality and morbidity in the neonatal period and beyond as they are more likely to have neonatal infections, perinatal respiratory distress syndrome, jaundice, polycythemia, hypoglycemia, poor feeding, and hypothermia [1,3,6]. Furthermore, infants born SGA are at higher risk of long-term adverse health outcomes, such as coronary artery disease, stroke, hypertension and type 2 diabetes [7]. Improving these short-and long-term outcomes requires improved diagnosis of SGA, so that appropriate surveillance and management strategies are in place.…”